Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Apr 01, 2024

SELL
$191.51 - $216.16 $1.42 Million - $1.6 Million
-7,406 Closed
0 $0
Q2 2023

Apr 01, 2024

SELL
$187.64 - $206.25 $1.9 Million - $2.09 Million
-10,136 Reduced 57.78%
7,406 $1.43 Billion
Q1 2023

Apr 01, 2024

BUY
$127.59 - $203.08 $95,692 - $152,310
750 Added 4.47%
17,542 $3.55 Billion
Q4 2022

Apr 01, 2024

BUY
$117.37 - $139.17 $20,891 - $24,772
178 Added 1.07%
16,792 $2.16 Billion
Q3 2022

Apr 01, 2024

BUY
$135.27 - $180.11 $5,410 - $7,204
40 Added 0.24%
16,614 $2.27 Billion
Q2 2022

Apr 01, 2024

BUY
$108.81 - $179.33 $99,343 - $163,728
913 Added 5.83%
16,574 $2.93 Billion
Q1 2022

Apr 01, 2024

BUY
$119.61 - $157.85 $31,696 - $41,830
265 Added 1.72%
15,661 $2.26 Billion
Q4 2021

Apr 01, 2024

BUY
$142.57 - $190.86 $4,562 - $6,107
32 Added 0.21%
15,396 $2.38 Billion
Q3 2021

Apr 01, 2024

BUY
$142.45 - $169.82 $325,498 - $388,038
2,285 Added 17.47%
15,364 $2.61 Billion
Q2 2021

Apr 01, 2024

BUY
$135.08 - $161.1 $102,930 - $122,758
762 Added 6.19%
13,079 $2.06 Billion
Q1 2021

Apr 01, 2024

BUY
$137.51 - $190.8 $14,851 - $20,606
108 Added 0.88%
12,317 $1.71 Billion
Q4 2020

Apr 01, 2024

BUY
$164.63 - $211.93 $2.01 Million - $2.59 Million
12,209 New
12,209 $2.14 Billion

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Azzad Asset Management Inc /Adv Portfolio

Follow Azzad Asset Management Inc /Adv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Azzad Asset Management Inc /Adv, based on Form 13F filings with the SEC.

News

Stay updated on Azzad Asset Management Inc /Adv with notifications on news.